Exchange: NASDAQ·Updated 09:30 AM EDT

AFMDAffimed N.V.

$0.0001
$0.00
(0.00%)
Today
Reported EarningsNov 14
Mkt Cap$1,523.00
Vol1,199.00

About

Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. It operates through the Germany and USA geographical segments. The company was founded in 2000 and is headquartered in Mannheim, Germany.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Affimed N.V.?
What is the 52-week high for Affimed N.V.?
What is Affimed N.V. stock price today?
What was Affimed N.V. stock price yesterday?
What is the 50-day moving average of Affimed N.V.?

Advertisement|Remove ads.